Bharat Biotech signs pact to supply 20 million doses of Covaxin to Brazil
Several countries around the world have expressed strong interest in Covaxin and the company was fully committed to ensuring supplies promptly and efficiently, the release added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 26, 2021 Category: Pharmaceuticals Source Type: news

PLI scheme: Government approves 19 applications for domestic manufacturing of APIs, key drug intermediates
Five applications with a committed investment of Rs 3,761 crore have already been approved under Target Segment I, the official statement said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 26, 2021 Category: Pharmaceuticals Source Type: news

Natco Pharma launches epilepsy treatment drug Brivaracetam in India
The company has launched Brivaracetam tablets under brand BRECITA in India, Natco Pharma said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 26, 2021 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for antidepressant drug
Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Nortriptyline Hydrochloride capsules USP, in strengths of 10 mg, 25 mg, 50 mg and 75 mg, Cadila Healthcare said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 25, 2021 Category: Pharmaceuticals Source Type: news

Pfizer-BioNTech testing booster of their COVID-19 vaccine in new trial
They are also in talks with regulatory authorities about testing a vaccine modified to protect specifically against the highly transmissible new variant found in South Africa and elsewhere, known as B.1.351, as a second arm of the same study. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 25, 2021 Category: Pharmaceuticals Source Type: news

Tie-up with Serum Institute of India key to mass production of COVID vaccines, say two pharma majors
"Together with our partner, the Serum Institute of India, we plan to supply over 300 million doses to 145 countries through COVAX in the first half of 2021 as part of our global and equitable access pledge," Ruud Dobber, president of AstraZeneca's biopharmaceuticals business, said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 25, 2021 Category: Pharmaceuticals Source Type: news

118 European MPs ask EU to lift opposition to TRIPS waiver proposal for accessible vaccines
This call comes in view of the European Council meeting on Thursday and the crucial decision to be made by all Member States at the WTO General Council on March 1-2. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 25, 2021 Category: Pharmaceuticals Source Type: news

In boost for COVID-19 battle, Pfizer vaccine found 94% effective in real world
The research in Israel - two months into one of the world's fastest rollouts, providing a rich source of data - showed two doses of the Pfizer shot cut symptomatic COVID-19 cases by 94% across all age groups, and severe illnesses by nearly as much. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 25, 2021 Category: Pharmaceuticals Source Type: news

Show big heart ´╗┐to back proposal for easy access to medicines: Piyush Goyal to global pharma
“I am sure the industry will show big heart across the world and support the TRIPS waiver that India has proposed at the WTO so that the entire world can come out of the covid pandemic much faster and bring back the 'V 'shaped recovery to the entire world,” Goyal said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 25, 2021 Category: Pharmaceuticals Source Type: news

Government continuously working to improve ease of doing business in pharma sector: Minister
"Under the leadership of Prime Minister Narendra Modi, the government continues to strive to improve the ease of doing business in the country. Vigorous effort is on to reduce the regulatory compliance burden on the (pharma) industry," Gowda said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 25, 2021 Category: Pharmaceuticals Source Type: news

Cabinet approves Rs 15,000 crore PLI scheme for pharma sector
The Union Cabinet, chaired by Prime Minister Narendra Modi, approved the scheme which will benefit domestic manufacturers, help create employment and is expected to contribute to the availability of a wider range of affordable medicines for consumers. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 24, 2021 Category: Pharmaceuticals Source Type: news

Realisation there in pharma industry to become self reliant in API production: IPA
"Reliance on China for APIs is there...We had the technology of making all kinds of APIs but over a period of time we lost that advantage. But now with production linked incentive (PLI) scheme which covers APIs and coming up of manufacturing parks we are on the right path," (IPA) Secretary General Sudarshan Jain said during an event. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 24, 2021 Category: Pharmaceuticals Source Type: news

Strides Pharma Science arm gets American drug regulator's nod for pain relieving drug
Strides Pharma Global Pte. Limited, Singapore, has received approval for Ibuprofen Oral Suspension USP, 100 mg/5 mL from the United States Food and Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 24, 2021 Category: Pharmaceuticals Source Type: news

Sun Pharma to launch complete range of generic anti-epilepsy drug
The drug major introduced Brevipil (Brivaracetam) tablet in strengths of 25 mg/50 mg/75 mg/100 mg on February 21, while Brevipil oral solution (10 mg/ml) and injectable (10 mg/ml) will be available in the market over the next few weeks. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 23, 2021 Category: Pharmaceuticals Source Type: news

Indian pharmaceutical firms go local for APIs, seeking to end reliance on China
Though India is known as the pharmacy of the world for its massive production capacities of both generic drugs and vaccines, China accounted for half of its API needs in 2019 from nearly nothing three decades ago, industry data shows. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 23, 2021 Category: Pharmaceuticals Source Type: news

USFDA rules against Sun Pharma Advanced Research Co's appeal regarding cancer drug application
The Office of New Drugs (OND) of the US Food and Drug Administration (FDA) has denied the company's appeal of the Complete Response Letter (CRL) in relation to the New Drug Application (NDA) for Taclantis, Sun Pharma Advanced Research Company (SPARC) said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 23, 2021 Category: Pharmaceuticals Source Type: news

65% of vaccines manufactured in Hyderabad, says Bharat Biotech's Krishna Ella
Krishna Ella, whose firm developed India's first indigenous vaccine for Covid-19, said 'pandemic vaccines and everything in future will come from Hyderabad'. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2021 Category: Pharmaceuticals Source Type: news

Indian vaccine makers say can quickly adapt to tackle variants
In all, India has reported more than 11 million coronavirus infections, the highest number in the world after the United States, and about 156,000 deaths. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2021 Category: Pharmaceuticals Source Type: news

No vaccine supply pact with Serum yet: Canada
Canada has not yet signed a procurement agreement with Serum Institute of India (SII) for the supply of the AstraZeneca-University of Oxford Covid-19 vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2021 Category: Pharmaceuticals Source Type: news

Glenmark arm gets Russian health ministry nod for nasal spray Ryaltris
In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent. Allergic rhinitis can impact a person's quality of life and lead to functional impairments, as well as increase the risk of having asthma, the company said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2021 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches stomach, esophagus problems treatment drug in the US
Quoting IQVIA Health data, Dr Reddy's said the Prevacid brand and generic had US sales of approximately USD 87 million for the most recent 12 months ending in December 2020. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2021 Category: Pharmaceuticals Source Type: news

Operational guidelines launched for integration of Non-Alcoholic Fatty Liver Disease with NPCDCS
"Over the last two decades global burden of NASH has more than doubled. Globally, NASH caused 40 lakh prevalent cases of compensated cirrhosis in 1990, which increased to 94 lakh cases in 2017. NAFLD is emerging as an important cause of liver disease in India," Vardhan was quoted as saying in a Health Ministry statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 22, 2021 Category: Pharmaceuticals Source Type: news

Serum Institute says it's prioritising domestic vaccine needs, urges countries to be patient
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 21, 2021 Category: Pharmaceuticals Source Type: news

Mamaearth to hire 200 people this year, crosses Rs 500 cr-revenue run rate
Mamaearth is now a Rs 500 crore-run rate brand, making it one of the fastest growing personal care brand to reach the milestone in less than four years of existence, Honasa Consumer co-founder& CEO Varun Alagh said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 21, 2021 Category: Pharmaceuticals Source Type: news

Adar Poonawalla urges countries please be patient, Serum directed to prioritise India needs
"Dear countries and governments, as you await #COVISHIELD supplies, I humbly request you to please be patient, @SerumInstIndia has been directed to prioritise the huge needs of India and along with that balance the needs of the rest of the world. We are trying our best", Poonawalla said in a tweet. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 21, 2021 Category: Pharmaceuticals Source Type: news

Baba Ramdev's Patanjali Ayurved claims it has a WHO-approved Covid medicine
Patanjali promoter, yoga guru Baba Ramdev, released a scientific research paper in this regard at the launch, presided over by Union health minister Harsh Vardhan and transport minister Nitin Gadkari. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Single dose of Pfizer and Astrazeneca Covid vaccines highly effective: Studies
Israeli studies have found the Pfizer vaccine to be 95 percent effective one week after a second jab, while the Lancet report focused on more than 9,000 medical staff at Sheba hospital near Tel Aviv. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Unichem Laboratories gets USFDA nod for plaque psoriasis treatment drug
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Zydus Cadila gets USFDA nod for low blood pressure drug
Zydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Droxidopa capsules in the strength of 100 mg, 200 mg, and 300 mg, Cadila Healthcare said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Baba Ramdev launches Patanjali's 'evidence-based' medicine for Covid-19
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Aurobindo Pharma gets USFDA nod for generic Droxidopa capsules
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Droxidopa capsules in the strengths of 100 mg, 200 mg and 300 mg, Aurobindo Pharma said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Post Covid-19, Ayurveda economy risen 50-90%: Harsh Vardhan
(Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Dr Reddy's seeks emergency use authorization for Russia's Sputnik V vaccine
Dr. Reddy's had been working with the Russian Direct Investment Fund (RDIF) to hold small domestic clinical studies of Sputnik V, which has proved 91.6% effective against COVID-19 based on late-stage trials in Russia. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Lupin gets USFDA nod for generic drug
Drugmaker Lupin on Friday said it has received approval from the US health regulator to market Droxidopa capsules, used to treat dizziness. The company has received approval from the US Food and Drug Administration (USFDA) for Droxidopa capsules in strengths of 100 mg, 200 mg, and 300 mg. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Pfizer first dose 85% effective after 2-4 weeks: Study
Israeli studies have found the Pfizer vaccine to be 95 percent effective one week after a second jab, while the Lancet report focused on more than 9,000 medical staff at Sheba hospital near Tel Aviv. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Pfizer submits data showing Covid-19 vaccine's stability in refrigerators
Pfizer/BioNTech's vaccine, along with Moderna Inc's two-dose vaccine, won the U.S. emergency use authorization (EUA) and is being widely distributed as part of the country's mass vaccination efforts. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Pharma sector study: CCI starts consultation process with companies, doctors, other stakeholders
"The idea behind the consultation is to gather insights on issues that may have a bearing on competition in the pharmaceutical market in India," the regulator said in a public notice. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 19, 2021 Category: Pharmaceuticals Source Type: news

Researchers urge delay in administering second dose of Pfizer's Covid-19 vaccine, cite strong data
In its response, Pfizer said that alternative dosing regimens of its vaccine had not been evaluated yet and the decision to do that resided with the health authorities. "We at Pfizer believe that it is critical for health authorities to conduct surveillance on implemented alternative dosing schedules to ensure that vaccines provide the maximum possible protection," the company added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 18, 2021 Category: Pharmaceuticals Source Type: news

'Rail Roko' protest: Delhi Police steps up security near tracks
The Samyukta Kisan Morcha (SKM), an umbrella body of farmer unions which is spearheading the protest, last week had announced the rail blockade to press for its demand to repeal the legislations. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 18, 2021 Category: Pharmaceuticals Source Type: news

Bharat Biotech pursues COVID-19 vaccine approval in over 40 countries
"We have submitted our documentation in Brazil and other countries and await their approval. We plan to export several million doses to Brazil," the company said in an emailed statement. "Pricing of COVAXIN for international markets will be based upon supply timelines, purchase commitments and procurement volumes," it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 18, 2021 Category: Pharmaceuticals Source Type: news

Lupin launches Posaconazole delayed-release tablets
In a regulatory filing, Lupin Ltd announced launch of Posaconazole delayed-release tablets, 100 mg, after its alliance partner AET Pharma US Inc. received an approval for its abbreviated new drug application from USFDA. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 17, 2021 Category: Pharmaceuticals Source Type: news

Dr Reddy's Laboratories launches cancer treatment drug Capecitabine in US
The product is a therapeutic equivalent generic version of Xeloda (capecitabine) tablets approved by the US Food and Drug Administration (USFDA). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 17, 2021 Category: Pharmaceuticals Source Type: news

Dharmendra Pradhan seeks Centre of Excellence on Marine Biotechnology in Odisha
In a letter to the Union science and technology minister on Tuesday, Pradhan said, the state's coastline provides employment to millions and has been at the centre of Prime Minister Narendra Modi's vision for a marine-led Blue Economy. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 17, 2021 Category: Pharmaceuticals Source Type: news

GSK, Vir Biotech to expand COVID-19 research partnership for other diseases
As a part of the deal to research and develop monoclonal antibody treatments for influenza and other respiratory illnesses, GSK will make a further $120 million equity investment in Vir and an additional upfront payment of $225 million. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 17, 2021 Category: Pharmaceuticals Source Type: news

Biocon Biologics to partner with International Diabetes Federation
Global Head of Market Access& Policy, Biocon Biologics, Alexander Zach, said:"Given our extensive experience in providing affordable insulins globally, we believe we can contribute and support IDF in driving real policy and access actions that will transform lives and diabetes care." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 16, 2021 Category: Pharmaceuticals Source Type: news

Glenmark launches kidney cancer treatment drug in India priced 96% lower than innovator brand
In a regulatory filing, Glenmark Pharma said it launched "SUTIB, the generic version of Sunitinib oral capsules to treat kidney cancer in India. The drug is launched at a MRP that is approximately 96 per cent lower than the MRP (maximum retail price) compared to the innovator brand, priced at Rs 7,000 (50 mg), Rs 3,600 (25 mg) and Rs 1,840 (12.5 mg) per month". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 16, 2021 Category: Pharmaceuticals Source Type: news

India to multiply vaccinations amid coverage concerns
Having reported the highest number of coronavirus infections after the United States, and with the world's biggest vaccine-making capacity, India says it has been the fastest to reach many inoculation milestones. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 16, 2021 Category: Pharmaceuticals Source Type: news

Serum Institute of India says will ship AstraZeneca Covid-19 vaccine to Canada in 'less than a month'
"As we await regulatory approvals from Canada, I assure you, @SerumInstIndia will fly out #COVISHIELD to Canada in less than a month; I'm on it!" CEO Adar Poonawalla said on Twitter, referring to a brand name for AstraZeneca's vaccine. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 15, 2021 Category: Pharmaceuticals Source Type: news

Lupin, Aurobindo units recall products in US market
The drug is used to relieve mild to moderate pain and reduce fever. USFDA noted that Lupin has initiated the recall of the affected lot due to,"Failed Impurities/Degradation Specifications". (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 14, 2021 Category: Pharmaceuticals Source Type: news

Alembic Global Holding SA gets USFDA nod for pulmonary arterial hypertension treatment injection
Drug firm Alembic Pharmaceuticals on Friday said its arm, Alembic Global Holding SA, has received approval from the US health regulator for its generic Treprostinil injection used for the treatment of pulmonary arterial hypertension. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 12, 2021 Category: Pharmaceuticals Source Type: news